This course has expired. View available courses.
Endocrinology
Advancement of Antihyperglycemic Therapy: The Management of Type 2 Diabetes is evolving with new data (CSEM)
This program has received an unrestricted educational grant or in-kind support from Novo Nordisk A/S.
DURATION
1 hr
PROFESSION
Physician, Nursing, Specialist
# OF CREDITS
1
ACCREDITATION
MOC - Section 1
EXPIRY DATE
2022-09-14
This program has received an unrestricted educational grant or in-kind support from Novo Nordisk A/S.
Faculty
Peter Lin, MD, CCFP (moderator)
Kim Connelly, MBBS PhD FSCMR FCCS
Roopa Mehta, MBBS, MRCP
Dipesh Patel, BSc, MBBS PhD, MRCP
Dirk Pilat, FRCGP, PgDipGP, BSc
David Strain, MBChB MD FRCP
Rene Wong, MD, FRCPC, MEd
Learning objectives
- Discuss the frequency and factors associated with therapeutic inertia in type 2 diabetes
- Review the evolving management of type 2 diabetes beyond simply glycemic control but a reduction in both micro and macrovascular complications
- Review what may be triggers for treatment escalation
- HbA1c rising
- Progression of microvascular disease
- Atherosclerotic event
- New diagnosis of heart failure or CKD